Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AnGes (AMGXF)
:AMGXF
Holding AMGXF?
Track your performance easily
AMGXF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.23 - $0.69
Previous CloseN/A
Volume2.05K
Average Volume (3M)68.00
Market Cap
$96.38M
Enterprise Value$14.87B
Total Cash (Recent Filing)$995.62M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.32
Next Earnings
Feb 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.29
Shares Outstanding286,377,560
10 Day Avg. Volume0
30 Day Avg. Volume68
Standard Deviation0.20
R-Squared0.00003
Alpha-0.13
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)319.71
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap154.26
Enterprise Value/Revenue226.88
Enterprise Value/Gross Profit2.00K
Enterprise Value/Ebitda-0.93
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Mutual Funds
― Other Institutional Investors
99.94% Public Companies and
Individual Investors
AMGXF FAQ
What was AnGes ’s price range in the past 12 months?
AnGes lowest stock price was $0.23 and its highest was $0.69 in the past 12 months.
What is AnGes ’s market cap?
AnGes ’s market cap is $96.38M.
When is AnGes ’s upcoming earnings report date?
AnGes ’s upcoming earnings report date is Feb 07, 2025 which is in 23 days.
How were AnGes ’s earnings last quarter?
AnGes released its earnings results on Nov 08, 2024. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.1.
Is AnGes overvalued?
According to Wall Street analysts AnGes ’s price is currently Overvalued.
Does AnGes pay dividends?
AnGes does not currently pay dividends.
What is AnGes ’s EPS estimate?
AnGes ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AnGes have?
AnGes has 286,377,560 shares outstanding.
What happened to AnGes ’s price movement after its last earnings report?
AnGes reported an EPS of -$0.1 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of AnGes ?
Currently, no hedge funds are holding shares in AMGXF
---
Company Description
AnGes
AnGes, Inc. engages in the research and development of gene-based medical products. It offers genetic medicines such as hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, and others. It is also involved in the research and development of medical equipment, which improves blood circulation by regenerating blood vessels and NfkB which controls various inflammations. The company was founded on December 17, 1999 and is headquartered in Ibaraki, Japan.
---
Technical Analysis
Sumitomo Dainippon Pharma Co
―
Shionogi & Co
―
Chugai Pharmaceutical Co
―
Nippon Shinyaku Co., Ltd.
―
Eisai Co
―
---